BioCryst Pharmaceuticals BCRX Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's preferred stock, shares authorized?
- BioCryst Pharmaceuticals (BCRX) reported preferred stock, shares authorized of $5M in Q1 2026.
- How has BioCryst Pharmaceuticals's preferred stock, shares authorized changed year-over-year?
- BioCryst Pharmaceuticals's preferred stock, shares authorized decreased by 0.0% year-over-year, from $5M to $5M.
- What is the long-term trend for BioCryst Pharmaceuticals's preferred stock, shares authorized?
- Over 3 years (2022 to 2025), BioCryst Pharmaceuticals's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $5M to $5M.